GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,322,000 | +3315.2% | 401,197 | +2665.2% | 0.06% | +5500.0% |
| Q3 2020 | $800,000 | -39.3% | 14,509 | -30.6% | 0.00% | -50.0% |
| Q2 2020 | $1,319,000 | -11.6% | 20,904 | -28.4% | 0.00% | 0.0% |
| Q1 2020 | $1,492,000 | -28.9% | 29,199 | +10.6% | 0.00% | 0.0% |
| Q4 2019 | $2,098,000 | +409.2% | 26,389 | +211.0% | 0.00% | – |
| Q3 2019 | $412,000 | -73.0% | 8,484 | -70.7% | 0.00% | -100.0% |
| Q2 2019 | $1,525,000 | +193.3% | 29,000 | +195.4% | 0.00% | 0.0% |
| Q1 2019 | $520,000 | -66.5% | 9,817 | -74.3% | 0.00% | -50.0% |
| Q4 2018 | $1,553,000 | -4.0% | 38,129 | -10.4% | 0.00% | +100.0% |
| Q3 2018 | $1,617,000 | -24.2% | 42,542 | -9.8% | 0.00% | -50.0% |
| Q2 2018 | $2,132,000 | +14.3% | 47,183 | +22.2% | 0.00% | 0.0% |
| Q1 2018 | $1,865,000 | -1.9% | 38,605 | -20.1% | 0.00% | 0.0% |
| Q4 2017 | $1,902,000 | – | 48,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
| VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
| Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
| RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
| Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
| RA Capital Management | 457,142 | $14,779,000 | 1.46% |
| VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
| Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
| Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |